Enforcement Report - Week of March 30, 2022
Actavis Mid Atlantic’s Generic Hydrocortisone Butyrate Receives Approval In US
Teligent Pharma’s Generic Hydrocortisone Butyrate Receives Approval In US
LEO Pharma A/S, a global healthcare company dedicated to helping people achieve healthy skin, and Japanese pharmaceutical company Astellas Pharma Inc. today announced that they have entered into an Asset Purchase Agreement under which Astellas will transfer its global dermatology business to LEO Pharma for € 675 million.